Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy
Open Access
- 15 October 2010
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 26 (4), 523-533
- https://doi.org/10.1007/s00467-010-1637-4
Abstract
Glomerular thrombotic microangiopathy is a hallmark feature of haemolytic uraemic syndrome, the leading cause of acute renal failure in childhood. This paper is a review of the different mechanistic pathways that lead to this histological picture in the kidney. It will focus on atypical HUS and complement dysregulation, but will also highlight some other recent advances in our understanding of this condition, including the potential role of the molecule vascular endothelial growth factor- A (VEGF-A).Keywords
This publication has 50 references indexed in Scilit:
- Shiga toxins — from cell biology to biomedical applicationsNature Reviews Microbiology, 2009
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2009
- Shiga Toxin 2 Targets the Murine Renal Collecting Duct EpitheliumInfection and Immunity, 2009
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraBlood, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Pathogenesis of Thrombotic MicroangiopathiesAnnual Review Of Pathology-Mechanisms Of Disease, 2008
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsThe Journal of Experimental Medicine, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- The molecular biology of thrombotic microangiopathyKidney International, 2006